查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1592903

生育治療市場：按產品類型、程序、患者類型、最終用戶 - 2025-2030 年全球預測

Infertility Treatment Market by Product (Accessories, Equipment, Media & Consumables), Procedure (Artificial Insemination, Assisted Reproductive Technology, Fertility Surgeries), Patient type, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，生育治療市場價值為53.5億美元，預計到2024年將達到59.3億美元，複合年成長率為11.26%，預計到2030年將達到113億美元。

不孕症治療市場包括各種旨在幫助無法自然受孕的個人和夫婦的治療方法。這些治療包括體外受精 (IVF) 等輔助生殖技術 (ART)、生育藥物、手術和其他干預措施。由於生活方式因素、健康狀況、延遲生育等原因，越來越多的人面臨不孕不育的挑戰，因此需要不孕症治療。最終用途範圍主要包括生育診所、醫院、手術中心以及越來越多透過專業生育中心提供的服務。該市場的主要成長要素包括輔助生殖技術的技術進步、不孕症治療資金和保險覆蓋範圍的增加以及人們對不孕症治療的認知不斷提高。然而，某些限制和挑戰仍然存在，例如與治療相關的高成本、文化和社會偏見以及因地區而異的監管情況。

主要市場統計
基準年[2023] 53.5億美元
預測年份 [2024] 59.3億美元
預測年份 [2030] 113億美元
複合年成長率（%） 11.26%

最新的潛在治療機會在於開發更具成本效益和侵入性較小的治療方案，這主要是由診斷工具和個人化醫療方法的創新所推動的。此外，鑑於可支配收入的增加和人口結構的變化，新興市場提供了巨大的商機。為相關人員提供的研究建議包括投資研究以提高治療成功率並減少副作用，與醫療保健提供者合作以提高可及性，以及非人性化不孕症問題的例子包括客戶教育措施。有關 ART 的嚴格監管要求和道德問題等限制可能會減緩市場成長。儘管存在這些挑戰，該市場仍存在創新領域，特別是在基因篩檢和胚胎選擇技術方面，這些技術可以提高成功率並完善個人化治療。市場正在向綜合護理方法發展，將醫療治療與諮詢和營養指導等支持服務相結合，提供符合消費者偏好的整體解決方案。

市場動態：揭示快速發展的生育市場的關鍵市場洞察

供需的動態交互作用正在改變不孕症治療市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 全球基礎建設計劃不斷湧現
    • 由於可靠性和耐用性，對導線管的潛在需求
    • 智慧電網網路快速擴張
  • 市場限制因素
    • 對原物料電壓的擔憂
  • 市場機會
    • 數位化導致用電量快速增加
    • 電網基礎設施的持續維修和維修活動
  • 市場挑戰
    • 安裝過程困難，佈線缺陷難以發現

波特五力：駕馭生育市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解生育治療市場的外在影響

外部宏觀環境因素在塑造不孕症治療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解不孕症治療市場的競爭狀況

生育治療市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV 定位矩陣生育治療市場供應商的績效評估

FPNV定位矩陣是評估生育市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了生育治療市場的成功之路

對於希望加強在全球市場的影響力的公司來說，生育治療市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球基礎建設計劃不斷增加
      • 由於可靠性和耐用性，對電氣導管的潛在需求
      • 智慧電網網路快速擴張
    • 抑制因素
      • 原物料價格波動的擔憂
    • 機會
      • 數位化導致用電量增加
      • 電網基礎設施的持續維修和改造活動
    • 任務
      • 安裝過程困難，接線缺陷難以發現
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 生育治療市場：依產品

  • 配件
  • 裝置
    • 冷凍系統
    • 氣體分析儀
    • 影像系統
    • 培養箱
    • 雷射系統
    • 顯微作業系統
    • 顯微鏡
    • 抽卵子泵
    • 精子分析系統
    • 精子分離裝置
  • 媒體和用品

第7章 不孕症市場的程序

  • 人工授精
    • 子宮頸內人工授精
    • 輸卵管內授精
    • 子宮內人工授精
  • 輔助生殖技術
    • 體外受精
      • 配子捐贈
      • 形態選擇精子的胞漿內注射
    • 卵細胞質內單一精蟲顯微注射術
    • 代孕
  • 不孕不育治療手術
    • 子宮鏡檢查
    • 腹腔鏡檢查
    • 開放性手術
    • 顯微外科重組
      • 輸精管睪丸切開術
      • 血管造口術
    • 子宮肌瘤切除術
    • 輸卵管結紮松解術
    • 靜脈曲張切除術

第8章按患者類型分類的生育治療市場

  • 女性不孕症治療
  • 男性不孕症治療

第9章 生育治療市場：依最終使用者分類

  • 冷凍庫
  • 不孕不孕治療中心
  • 醫院和外科診所
  • 調查機構

第10章美洲生育治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太生育治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的生育治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • ABB Limited
  • Aliaxis Group SA
  • ANAMET Electrical, Inc.
  • Astral PolyTechnik Limited
  • Atkore International Holdings Incorporated
  • Cantex, Inc.
  • China Lesso Group Holdings Ltd.
  • Dura-line Corporation
  • Electri-Flex Company
  • Hellermanntyton group plc
  • Hubbell Incorporated
  • Legrand SA
  • Nan Ya Plastics Corp.
  • National pipe & plastics, Inc.
  • Orbia Advance Corporation
  • Schneider Electric SE
  • Sekisui Chemical Co., Ltd.
  • Thomas & Betts Corporation
  • Wienerberger AG
  • Zekelman Industries Inc.
Product Code: MRR-3E32260F8122

The Infertility Treatment Market was valued at USD 5.35 billion in 2023, expected to reach USD 5.93 billion in 2024, and is projected to grow at a CAGR of 11.26%, to USD 11.30 billion by 2030.

The infertility treatment market encompasses a range of therapeutic approaches aimed at aiding individuals and couples unable to conceive naturally. These treatments include assisted reproductive technologies (ART) like in vitro fertilization (IVF), fertility drugs, surgeries, and other interventions. The necessity for infertility treatments arises from the growing number of individuals facing fertility challenges due to lifestyle factors, health conditions, and delayed childbearing. The end-use scope primarily includes fertility clinics, hospitals, and surgical centers, with an increasing number of services also being offered through specialized fertility centers. Key growth factors for this market include technological advancements in ART, increased funding and insurance coverage for infertility treatments, and growing awareness regarding fertility preservation. However, certain limitations and challenges remain, such as the high costs associated with treatments, cultural and social stigmas, and varying regulatory landscapes across regions.

KEY MARKET STATISTICS
Base Year [2023] USD 5.35 billion
Estimated Year [2024] USD 5.93 billion
Forecast Year [2030] USD 11.30 billion
CAGR (%) 11.26%

Latest potential opportunities lie in the development of more cost-effective and minimally invasive treatment options, largely driven by innovation in diagnostic tools and personalized medicine approaches. Additionally, emerging markets present significant opportunities, given the increasing disposable income and changing demographics. Recommendations for stakeholders include investing in research to improve success rates of treatments and reduce side-effects, enhancing accessibility through partnerships with healthcare providers, and engaging in customer education initiatives to destigmatize infertility issues. Limitations such as stringent regulatory requirements and ethical concerns related to ART can slow down market growth. Despite these challenges, the market offers areas of innovation, particularly in genetic screening and embryo selection technologies, which can increase success rates and refine personalization in treatments. The market is evolving towards an integrated care approach, combining medical treatments with supportive services like counseling and nutritional guidance, offering a holistic solution that is gaining favor in consumer preferences.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Infertility Treatment Market

The Infertility Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising number of infrastructure projects all over the world
    • Potential demand for electrical conduit owing to reliability and durability
    • Rapid extension of smart grid networks
  • Market Restraints
    • Concern associated with raw material voltality
  • Market Opportunities
    • Proliferation of electricity usage attributed to digitalization
    • Ongoing refurbishment and retrofit activities in grid infrastructure
  • Market Challenges
    • Difficulty in installation process coupled with hard to find defects in wiring

Porter's Five Forces: A Strategic Tool for Navigating the Infertility Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Infertility Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Infertility Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Infertility Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Infertility Treatment Market

A detailed market share analysis in the Infertility Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Infertility Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Infertility Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Infertility Treatment Market

A strategic analysis of the Infertility Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Infertility Treatment Market, highlighting leading vendors and their innovative profiles. These include ABB Limited, Aliaxis Group S.A., ANAMET Electrical, Inc., Astral PolyTechnik Limited, Atkore International Holdings Incorporated, Cantex, Inc., China Lesso Group Holdings Ltd., Dura-line Corporation, Electri-Flex Company, Hellermanntyton group plc, Hubbell Incorporated, Legrand S.A., Nan Ya Plastics Corp., National pipe & plastics, Inc., Orbia Advance Corporation, Schneider Electric SE, Sekisui Chemical Co., Ltd., Thomas & Betts Corporation, Wienerberger AG, and Zekelman Industries Inc..

Market Segmentation & Coverage

This research report categorizes the Infertility Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Accessories, Equipment, and Media & Consumables. The Equipment is further studied across Cryosystems, Gas Analyzers, Imaging Systems, Incubators, Laser Systems, Micromanipulator Systems, Microscopes, Ovum Aspiration Pumps, Sperm Analyzer Systems, and Sperm Separation Devices.
  • Based on Procedure, market is studied across Artificial Insemination, Assisted Reproductive Technology, and Fertility Surgeries. The Artificial Insemination is further studied across Intracervical Insemination, Intratubal Insemination, and Intrauterine Insemination. The Assisted Reproductive Technology is further studied across In Vitro Fertilization, Intracytoplasmic Sperm Injection, and Surrogacy. The In Vitro Fertilization is further studied across Gamete Donation and Intracytoplasmic Morphologically Selected Sperm Injection. The Fertility Surgeries is further studied across Hysteroscopy, Laparoscopy, Laparotomy, Microsurgical Reconstruction, Myomectomy, Tubal Ligation Reversal, and Varicocelectomy. The Microsurgical Reconstruction is further studied across Vasoepididymostomy and Vasovasostomy.
  • Based on Patient type, market is studied across Female Infertility Treatment and Male Infertility Treatment.
  • Based on End User, market is studied across Cryobanks, Fertility Centers, Hospitals & Surgical Clinics, and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of infrastructure projects all over the world
      • 5.1.1.2. Potential demand for electrical conduit owing to reliability and durability
      • 5.1.1.3. Rapid extension of smart grid networks
    • 5.1.2. Restraints
      • 5.1.2.1. Concern associated with raw material voltality
    • 5.1.3. Opportunities
      • 5.1.3.1. Proliferation of electricity usage attributed to digitalization
      • 5.1.3.2. Ongoing refurbishment and retrofit activities in grid infrastructure
    • 5.1.4. Challenges
      • 5.1.4.1. Difficulty in installation process coupled with hard to find defects in wiring
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Infertility Treatment Market, by Product

  • 6.1. Introduction
  • 6.2. Accessories
  • 6.3. Equipment
    • 6.3.1. Cryosystems
    • 6.3.2. Gas Analyzers
    • 6.3.3. Imaging Systems
    • 6.3.4. Incubators
    • 6.3.5. Laser Systems
    • 6.3.6. Micromanipulator Systems
    • 6.3.7. Microscopes
    • 6.3.8. Ovum Aspiration Pumps
    • 6.3.9. Sperm Analyzer Systems
    • 6.3.10. Sperm Separation Devices
  • 6.4. Media & Consumables

7. Infertility Treatment Market, by Procedure

  • 7.1. Introduction
  • 7.2. Artificial Insemination
    • 7.2.1. Intracervical Insemination
    • 7.2.2. Intratubal Insemination
    • 7.2.3. Intrauterine Insemination
  • 7.3. Assisted Reproductive Technology
    • 7.3.1. In Vitro Fertilization
      • 7.3.1.1. Gamete Donation
      • 7.3.1.2. Intracytoplasmic Morphologically Selected Sperm Injection
    • 7.3.2. Intracytoplasmic Sperm Injection
    • 7.3.3. Surrogacy
  • 7.4. Fertility Surgeries
    • 7.4.1. Hysteroscopy
    • 7.4.2. Laparoscopy
    • 7.4.3. Laparotomy
    • 7.4.4. Microsurgical Reconstruction
      • 7.4.4.1. Vasoepididymostomy
      • 7.4.4.2. Vasovasostomy
    • 7.4.5. Myomectomy
    • 7.4.6. Tubal Ligation Reversal
    • 7.4.7. Varicocelectomy

8. Infertility Treatment Market, by Patient type

  • 8.1. Introduction
  • 8.2. Female Infertility Treatment
  • 8.3. Male Infertility Treatment

9. Infertility Treatment Market, by End User

  • 9.1. Introduction
  • 9.2. Cryobanks
  • 9.3. Fertility Centers
  • 9.4. Hospitals & Surgical Clinics
  • 9.5. Research Institutes

10. Americas Infertility Treatment Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Infertility Treatment Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Infertility Treatment Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ABB Limited
  • 2. Aliaxis Group S.A.
  • 3. ANAMET Electrical, Inc.
  • 4. Astral PolyTechnik Limited
  • 5. Atkore International Holdings Incorporated
  • 6. Cantex, Inc.
  • 7. China Lesso Group Holdings Ltd.
  • 8. Dura-line Corporation
  • 9. Electri-Flex Company
  • 10. Hellermanntyton group plc
  • 11. Hubbell Incorporated
  • 12. Legrand S.A.
  • 13. Nan Ya Plastics Corp.
  • 14. National pipe & plastics, Inc.
  • 15. Orbia Advance Corporation
  • 16. Schneider Electric SE
  • 17. Sekisui Chemical Co., Ltd.
  • 18. Thomas & Betts Corporation
  • 19. Wienerberger AG
  • 20. Zekelman Industries Inc.

LIST OF FIGURES

  • FIGURE 1. INFERTILITY TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. INFERTILITY TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INFERTILITY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. INFERTILITY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. INFERTILITY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INFERTILITY TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INFERTILITY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INFERTILITY TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY CRYOSYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY GAS ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INCUBATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MICROMANIPULATOR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY OVUM ASPIRATION PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY SPERM ANALYZER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY SPERM SEPARATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MEDIA & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRACERVICAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRATUBAL INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY GAMETE DONATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRACYTOPLASMIC MORPHOLOGICALLY SELECTED SPERM INJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY SURROGACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY HYSTEROSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY LAPAROSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY LAPAROTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY VASOEPIDIDYMOSTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY VASOVASOSTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MYOMECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY TUBAL LIGATION REVERSAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY VARICOCELECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FEMALE INFERTILITY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY MALE INFERTILITY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY CRYOBANKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY HOSPITALS & SURGICAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL INFERTILITY TREATMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 80. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 81. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. CANADA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 89. CANADA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 90. CANADA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 91. CANADA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. CANADA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 93. CANADA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 94. CANADA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 95. CANADA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. CANADA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 99. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 100. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 101. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 103. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 104. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 105. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. MEXICO INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 109. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 110. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 111. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 113. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 114. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 115. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. UNITED STATES INFERTILITY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 132. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 136. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 137. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. AUSTRALIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. CHINA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. CHINA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 141. CHINA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 142. CHINA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 143. CHINA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. CHINA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 145. CHINA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 146. CHINA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 147. CHINA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. CHINA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. INDIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. INDIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 151. INDIA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 152. INDIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 153. INDIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. INDIA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 155. INDIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 156. INDIA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 157. INDIA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. INDIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 161. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 162. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 163. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 165. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 166. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 167. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. INDONESIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 171. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 172. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 173. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 175. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 176. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 177. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. JAPAN INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 181. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 182. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 183. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 185. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 186. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 187. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. MALAYSIA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 192. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 196. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 197. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. PHILIPPINES INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 199. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 200. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 201. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 202. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 203. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 204. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 205. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 206. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 207. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SINGAPORE INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 211. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 212. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 213. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 216. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 217. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. SOUTH KOREA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 221. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 222. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 223. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 225. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 226. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 227. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. TAIWAN INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 229. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 230. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 231. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 232. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 233. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 234. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 235. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 236. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 237. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. THAILAND INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 239. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 241. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 242. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 243. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 244. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 245. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 246. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 247. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. VIETNAM INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA INFERTILITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 260. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 261. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 262. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 263. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 264. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 265. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 266. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 267. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 268. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. DENMARK INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 270. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 271. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 272. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 273. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 274. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 275. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 276. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 277. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 278. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. EGYPT INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 280. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 281. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 282. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 283. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 284. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 285. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 286. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 287. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 288. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 289. FINLAND INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 290. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 291. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 292. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 293. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 294. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 295. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 296. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 297. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 298. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 299. FRANCE INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 300. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 301. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 302. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 303. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 304. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 305. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 306. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 307. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 308. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 309. GERMANY INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 310. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 311. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 312. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 313. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATION, 2018-2030 (USD MILLION)
  • TABLE 314. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 315. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
  • TABLE 316. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY FERTILITY SURGERIES, 2018-2030 (USD MILLION)
  • TABLE 317. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY MICROSURGICAL RECONSTRUCTION, 2018-2030 (USD MILLION)
  • TABLE 318. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 319. ISRAEL INFERTILITY TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 320. ITALY INFERTILITY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 321. ITALY INFERTILITY TREATMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 322. ITALY INFERTILITY TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 323. ITALY INFERTILITY TREATMENT MARKET SIZE, BY ARTIFICIAL INSEMINATIO